| Year |
Citation |
Score |
| 2023 |
French AR, Meqbil YJ, van Rijn RM. ClickArr: a novel, high-throughput assay for evaluating β-arrestin isoform recruitment. Frontiers in Pharmacology. 14: 1295518. PMID 38027002 DOI: 10.3389/fphar.2023.1295518 |
0.71 |
|
| 2023 |
Hennessy MR, Gutridge AM, French AR, Rhoda ES, Meqbil YJ, Gill M, Kashyap Y, Appourchaux K, Paul B, Wang ZJ, van Rijn RM, Riley AP. Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of Medicinal Chemistry. PMID 36827198 DOI: 10.1021/acs.jmedchem.2c01707 |
0.666 |
|
| 2022 |
Meqbil YJ, Rijn RMV. Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors. Pharmaceuticals (Basel, Switzerland). 15. PMID 35890173 DOI: 10.3390/ph15070873 |
0.654 |
|
| 2021 |
Meqbil YJ, Su H, Cassell RJ, Mores KL, Gutridge AM, Cummins BR, Chen L, van Rijn RM. Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities. Molecules (Basel, Switzerland). 26. PMID 34885825 DOI: 10.3390/molecules26237236 |
0.707 |
|
| 2021 |
Sharma KK, Cassell RJ, Meqbil YJ, Su H, Blaine AT, Cummins BR, Mores KL, Johnson DK, van Rijn RM, Altman RA. Modulating β-arrestin 2 recruitment at the δ- and μ-opioid receptors using peptidomimetic ligands. Rsc Medicinal Chemistry. 12: 1958-1967. PMID 34825191 DOI: 10.1039/d1md00025j |
0.771 |
|
| 2021 |
Sharifi F, Meqbil YJ, Otte A, Gutridge AM, Blaine AT, van Rijn RM, Park K. Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid Overdose. Pharmaceutical Research. PMID 34114163 DOI: 10.1007/s11095-021-03069-x |
0.655 |
|
| 2021 |
Meqbil Y, Su H, Cassell R, Gutridge A, Cummins B, Chen L, Rijn R. Identification of a Novel δOR Selective Agonist Chemotype, Notably Devoid of a Basic Nitrogen The Faseb Journal. 35. DOI: 10.1096/FASEBJ.2021.35.S1.02503 |
0.309 |
|
| Show low-probability matches. |